Caroline Roan - Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The Pfizer @ Pfizer

Overview

CB Rank (Investor)

Primary Job Title Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The Pfizer
Primary Organization
Pfizer

Caroline Roan is a Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The Pfizer at Pfizer. She attended Earlham College.

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	International Rescue Committee	The Pfizer Foundation	Yes	Grant - International Rescue Committee	obfuscated obfuscation
obfuscated obfuscation	PATH	The Pfizer Foundation	Yes	Grant - PATH	obfuscated obfuscation
obfuscated obfuscation	CARE	The Pfizer Foundation	Yes	Grant - CARE	obfuscated obfuscation

Number of Current Jobs

Number of Past Jobs

has

current jobs as

Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The Pfizer

and

Vice President, Corporate Responsibility, President, Pfizer Foundation

. Additionally,

has had

past jobs including

Program Associate

Pfizer Chief Sustainability Officer | SVP, Global Health & Social Impact | President, The PfizerAug 2021
The Pfizer Foundation Vice President, Corporate Responsibility, President, Pfizer FoundationSep 2008

Organization Name	Title At Company	Start Date	End Date
The Robert Wood Johnson Foundation	Program Associate	May 2000	Apr 2001
Yale University School of Medicine	Study Coordinator	Apr 1996	Jul 1997
Brandeis University	Research Assistant	Sep 1992	Mar 1996

Hub Name	CB Rank (Hub)
East Coast Biotechnology Public Companies	48,002
Greater New York Area Pharmaceutical Companies	21,866
Greater New York Area Biotechnology Companies	25,463
Pharmaceutical Public Companies With More Than $500 in Revenue	48,207
United States Precision Medicine Companies	55,937
Corporate VC Investors with Investments in Greater New York Area	21,174
Medical Public Companies With More Than $1B in Revenue	49,732
East Coast Corporate VC Investors	59,579
Precision Medicine Companies that Exited	80,745
Pharmaceutical Public Companies With More Than 1000 Employees	41,356

studied at

There is no recent news or activity for this profile.